Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Gross Margin (2017 - 2025)

Historic Gross Margin for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to 86.59%.

  • Inspire Medical Systems' Gross Margin rose 16100.0% to 86.59% in Q4 2025 from the same period last year, while for Dec 2025 it was 85.39%, marking a year-over-year increase of 7100.0%. This contributed to the annual value of 85.39% for FY2025, which is 7100.0% up from last year.
  • As of Q4 2025, Inspire Medical Systems' Gross Margin stood at 86.59%, which was up 16100.0% from 85.85% recorded in Q3 2025.
  • Over the past 5 years, Inspire Medical Systems' Gross Margin peaked at 86.59% during Q4 2025, and registered a low of 81.88% during Q3 2022.
  • Over the past 5 years, Inspire Medical Systems' median Gross Margin value was 84.84% (recorded in 2024), while the average stood at 84.83%.
  • Per our database at Business Quant, Inspire Medical Systems' Gross Margin tumbled by -41400bps in 2022 and then surged by 22200bps in 2023.
  • Over the past 5 years, Inspire Medical Systems' Gross Margin (Quarter) stood at 85.77% in 2021, then fell by -2bps to 83.94% in 2022, then rose by 2bps to 85.43% in 2023, then decreased by -1bps to 84.99% in 2024, then grew by 2bps to 86.59% in 2025.
  • Its Gross Margin stands at 86.59% for Q4 2025, versus 85.85% for Q3 2025 and 84.03% for Q2 2025.